9th October 2020
News
Sygnature Discovery wins Medilink Outstanding Achievement Award
24th September 2020
News
Sygnature Discovery expands DMPK capabilities with acquisition of XenoGesis
9th September 2020
News
Sygnature and RenaSci strengthen drug abuse leadership with appointment of Dr Andy Mead
23rd June 2020
News
Sygnature Discovery boosts senior management team with appointment of Dr Paul Overton
11th June 2020
Drug Discovery News
Sygnature assists New York Medical College in the fight against Covid-19
3rd June 2020
News Therapeutic Areas
Sygnature expands capabilities with acquisition of Alderley Oncology
29th May 2020
Bioscience Drug Discovery News
Sygnature Discovery expands SPR capacity
22nd May 2020
News
Sygnature Group adds pharmacology expertise to BD team with recruitment of Dr David Loczenski
15th April 2020
News
Sygnature provides equipment to Government’s COVID-19 testing efforts
1st April 2020
News
Key Appointments and Retirements at RenaSci
25th March 2020
News
COVID-19 – Update
17th March 2020
News
COVID-19 and business continuity